News & Blog
Welcome to the Atelerix News & Blog - warm takes on keeping cells happy without the cold, with company updates & research insights (no frostbite required).
Featured articles
Atelerix launches STORganoid cryo-free preservation solution for complex 3D cell models
Ambient-temperature preservation solution enables reliable storage and shipment of organoids and spheroids, to support growing adoption of New Approach Methodologies […]
Atelerix forms strategic partnership with JH Health Ltd to expand non-cryogenic cell preservation capabilities in the Middle East
Agreement grants JH Health exclusive rights to use and distribute Atelerix’s portfolio of non-cryogenic preservation solutions in the region Expands […]
Two Years On: Stem Cell Therapy Brings Sustained Vision Improvement Thanks to Alginate-Based Delivery
At Atelerix, we’re proud to support pioneering work that translates innovative science into real-world patient impact. A recent clinical milestone […]
From Lab to Market: Recent Advances and Commercialisation of Organoid Technologies
By Sophie Reay Organoids are three-dimensional (3D) tissue cultures derived from stem cells that self-organise into structures that closely […]
Sunil Shah and Dr Catherine Elton join Atelerix’s Board to drive global commercial expansion
Sunil Shah and Dr Catherine Elton join Atelerix’s Board to drive global commercial expansion Industry-leaders Sunil Shah (CEO, o2h […]
Mini Organs, Major Impact: How Organoids Are Redefining Drug Development & Personalised Medicine
By Sophie Reay Organoids are miniature, three-dimensional (3D) tissue cultures that mimic the structure and function of specific organs. They […]
Grant Writing That Stands Out: How Ambient Cell Preservation Can Strengthen Your Application
Securing research funding is a competitive process. Review panels look for more than just sound science – they’re also seeking […]
Rise in the use of organoids to replace animal models: the issue with storage and shipment
By Sophie Reay, Historically, preclinical testing on animal models formed a critical step in the drug discovery and development pipeline, […]
Transforming mRNA Vaccine Distribution: How Atelerix’s CytoStor™ Could Eliminate the Need for the Ultracold Chain
As the global biotechnology sector works to extend the reach of life-saving mRNA vaccines, a persistent challenge remains: the carbon-intensive, […]
Two Years On: Stem Cell Therapy Brings Sustained Vision Improvement Thanks to Alginate-Based Delivery
At Atelerix, we’re proud to support pioneering work that translates innovative science into real-world patient impact. A recent clinical milestone […]
Atelerix signs exclusive agreement with MineBio to establish distribution channel for non-cryogenic cell preservation solutions in China
Partnership with specialist life science distributor establishes sales channel in high-demand market and strengthens global network Hypothermic preservation technology eliminates […]
We’re Finalists (Twice!) at the Medilink Healthcare Business Awards 2025
We’re thrilled to share some seriously good news: Atelerix has been shortlisted not once, but twice for the Medilink Healthcare […]
Atelerix Launches BloodReady™: A Breakthrough in Whole Blood Preservation
Newcastle, UK – [17.02.2025] – Atelerix, the pioneering biotech company revolutionising cell preservation, has unveiled BloodReady™, a first-of-its-kind solution that […]
Preserving Cell Functionality: Cryopreservation vs. Hypothermic Hydrogel Technology
By Rachel Sanders Preserving cell functionality during storage and transportation is challenging for cell-based therapies as cryopreservation methods can compromise […]
Rethinking Lab Infrastructure: Room Temperature Cell Storage Can Transform Your Research Facility
By Rachel Sanders In scientific research, efficiency and reliability are of the utmost importance, and one of the most persistent […]
Green Science: Reducing the Carbon Footprint of Cell Research with Eco-Friendly Preservation Methods
By Sarah Marsh In an era where environmental consciousness is paramount, the scientific community faces a unique challenge: balancing […]
Atelerix raises £750k to revolutionise biological transport
The biotech’s technology can transport cells in a more economically viable, higher performing and sustainable way Newcastle, UK – […]
Simplifying Multi-Site Clinical Trials: Ambient Temperature Cell Shipping Can Streamline Collaboration
By Rachel Sanders In multi-site clinical trials, cell preservation and transportation is a significant bottleneck. Coordinating shipments across multiple […]
